A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled Phase I clinical study of
TQ-A3334 tablets in adult healthy subjects, and the trial is planned to enroll 90 healthy
subjects.
The primary objective is to evaluate the safety and tolerability of TQ-A3334 tablets after
multiple doses in healthy subjects.